JP2002508172A - グルコース調節遺伝子 - Google Patents

グルコース調節遺伝子

Info

Publication number
JP2002508172A
JP2002508172A JP2000539057A JP2000539057A JP2002508172A JP 2002508172 A JP2002508172 A JP 2002508172A JP 2000539057 A JP2000539057 A JP 2000539057A JP 2000539057 A JP2000539057 A JP 2000539057A JP 2002508172 A JP2002508172 A JP 2002508172A
Authority
JP
Japan
Prior art keywords
hmunc13
sequence
nucleotide sequence
polypeptide
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000539057A
Other languages
English (en)
Japanese (ja)
Inventor
メルビン シルバーマン，
ヨン ソン，
Original Assignee
メルビン シルバーマン，
ヨン ソン，
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メルビン シルバーマン，, ヨン ソン， filed Critical メルビン シルバーマン，
Publication of JP2002508172A publication Critical patent/JP2002508172A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2000539057A 1997-12-12 1998-11-19 グルコース調節遺伝子 Pending JP2002508172A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6935297P 1997-12-12 1997-12-12
US60/069,352 1997-12-12
PCT/CA1998/001061 WO1999031134A1 (fr) 1997-12-12 1998-11-19 Gene a regulation glucosique

Publications (1)

Publication Number Publication Date
JP2002508172A true JP2002508172A (ja) 2002-03-19

Family

ID=22088397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000539057A Pending JP2002508172A (ja) 1997-12-12 1998-11-19 グルコース調節遺伝子

Country Status (5)

Country Link
EP (1) EP1040125A1 (fr)
JP (1) JP2002508172A (fr)
AU (1) AU1138899A (fr)
CA (1) CA2314141A1 (fr)
WO (1) WO1999031134A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
CA2314141A1 (fr) 1999-06-24
EP1040125A1 (fr) 2000-10-04
WO1999031134A1 (fr) 1999-06-24
AU1138899A (en) 1999-07-05

Similar Documents

Publication Publication Date Title
RU2761564C2 (ru) Композиции и способы деградации неправильно упакованных белков
US8211853B2 (en) Method of promoting apoptosis of differentiated adipocytes and increasing endogenous expression of SFRP-5 peptide by administration of SFRP-5 peptide
US20100105625A1 (en) Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders
US5756348A (en) DNA encoding a glycine transporter and uses thereof
Jin et al. Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic‐like blebbing in lens cells
US7345158B2 (en) Actin related cytoskeletal protein “LACS”
US5928941A (en) Repressor kruppel-like factor
JPH11341988A (ja) セマフォリンｋ１
JP2002508172A (ja) グルコース調節遺伝子
AU2004223739B2 (en) Cyclic AMP response element activator proteins and uses related thereto
JP2002517998A (ja) ｐ２７（ＫＩＰ１）のＦＫＢＰ−１２との相互作用
EP1613769B1 (fr) Gene induit par l'insuline utilise comme cible therapeutique dans le diabete
US20070231812A1 (en) Method of Screening Antidiabetic Agents
JP2003189883A (ja) 新規ユビキチン特異プロテアーゼ
JP4283531B2 (ja) マスト細胞の細胞死誘発剤
US20070015155A1 (en) Novel protein usable in screening drug improving type 2 diabetes
CA2258973A1 (fr) Gene regule par le glucose
US6967245B2 (en) Ucp5
US7342102B2 (en) Uncoupling protein 5 (UCP5)
WO2005093068A1 (fr) Nouvelle proteine et nouveau promoteur
US20040248829A1 (en) Functions for d52 and ra006 nucleic acids and polypeptides
CA2291962A1 (fr) Gene regule par le glucose
JP2002526075A (ja) Ｕｃｐ４
JP2002533062A5 (fr)
JP2006166703A (ja) 軟骨分化制御遺伝子